A study of the hematopoietic and iron metabolism effect of epoetin beta pegol on non-dialysis chronic kidney disease patients who do not respond well to darbepoetin alfa by monitoring hepcidin-25.
Not Applicable
- Conditions
- non-dialysis chronic kidney disease
- Registration Number
- JPRN-UMIN000009658
- Lead Sponsor
- Saiseikai yokohama-city tobu hospital
- Brief Summary
anemia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
the patients having allergy for epoetin beta pegol ,erythropoietin and darbepoetin alfa the patients of gastrointestinal hemorrhage the patients having or had liver damages
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of maintaining the target Hb level
- Secondary Outcome Measures
Name Time Method